
Happy Scribe
Transcription, subtitles & translation in 150+ languages
Details
- Follow on
- @happy_scribe
- Categories
- Video & Audio Tools
- Target Audience
- Content CreatorsRemote teamsStudents
- Pricing
- Freemium from $8.5
Discovery signals
How AI and people discover Happy Scribe on PeerPush
- ChatGPT
- Perplexity
- +4 other AI crawlers
Reads by these AI engines
Crawlers behind these engines read this listing on PeerPush.About Happy Scribe
The platform pairs AI transcription (85%+ accuracy, results in minutes) with optional professional human review (99% accuracy) so teams can choose speed or precision per file. A collaborative editor lets users clean up transcripts, identify speakers, generate and burn subtitles, and translate output into dozens of target languages — all in one workspace, no tool-switching. Key features: • AI + professional human transcription in 120+ languages and accents • Live meeting transcription via Zoom, Google Meet, and Microsoft Teams • Auto-generated and human-made subtitles with frame-accurate timing and custom styling • Translation across dozens of language pairs (machine and human) • Shared workspaces with role-based permissions and team billing • Exports to TXT, DOCX, PDF, SRT, VTT, EBU-STL, AVID, JSON, and more • Native integrations with Zoom, Google Drive, YouTube, Zapier, plus a public REST API • GDPR-compliant infrastructure with an EU data-hosting option What makes it different: most transcription tools force a choice between fast AI or accurate humans — Happy Scribe lets users mix both on the same file, and is one of the few platforms offering on-demand professional human subtitles in dozens of languages. Real outcomes: researchers cut interview-to-quote time by 60–80%, podcast producers ship episodes with translated subtitles the same day, and media teams at the BBC, Forbes, Spotify, and The New York Times rely on it for broadcast-grade captioning.
Product Video
Watch a video demo of Happy Scribe.
Screenshots
Reviews (2)
Average 4.5 out of 5
Based on 2 reviews



Comments (0)
No comments yet. Be the first to share your thoughts!